Introduction: Blood pressure (BP) control has been long known to have a role in reducing mortality and morbidity in type 2 diabetes (T2DM) patients. However, routine office BP measurement using brachial BP failed to represent true aortic BP reflected in target organs such as heart, kidney, and brain due to pulse pressure amplification and pulse wave reflection throughout the arterial tree. Several studies suggested that central BP might be a better predictor for cardiovascular (CV) risk than brachial BP in various populations. This study aimed to see the relationship between central systolic blood pressure (cSBP) with various demographic and diabetes-related parameters. Methods: This is a cross-sectional study involving 95 T2DM patients. Office blood pressure was measured using Omron® automatic sphygmomanometer. Meanwhile, central blood pressure was measured using SphygmoCor® XCEL. Diabetes-related parameters measured in this study are duration, A1C, and albumin-to-creatinine ratio (ACR). The analysis was conducted in all subjects, and in subgroup based on hypertensive status. Result: Among 95 T2DM patients were recruited; 70,5% of them are female. The mean age in this study was 48 years old (CI: 47,3 – 50,5); and mean BMI was 26 kg/m2 (CI: 25,6 – 27,3). Fifty-point-five percent of patients in this study were hypertensive. Central SBP were obviously, higher in patients with hypertension compared to non-hypertension (122,7 mmHg [CI: 93 – 191] vs 136,1 mmHg [CI: 131,4 – 140,8] respectively) and BP amplification (bSBP – cSBP) was more profound in hypertensive group (18,1 mmHg [CI:16,9 – 19,2]) compared to non-hypertensive group (14,5 mmHg [CI: 13,0 – 15,2]) respectively. Overall, a strong correlation found between bSBP and cSBP (R2 = 0,975). Multivariate analysis showed bSBP remained the only factor positively associated with cSBP. In subgroup analysis, bSBP showed strong correlation to cSBP both in hypertensive group and in non-hypertensive group (R2 = 0,987 and R2 = 0,977, respectively). In multivariate analysis, bSBP remained the only predictor of cSBP in hypertensive group, whereas in non-hypertensive group bSBP and female were predictors of cSBP. None of the diabetes-related parameters (duration, HbA1C, and ACR) are correlated with cSBP. Result: Agreement between cSBP and bSBP is very strong both in all subjects and in subgroup analysis. This might suggest that although cSBP proven superior than bSBP regarding CV risk predictor and target organ damage, high concordance correlation might suggest that these are still interchangeable, especially when central BP measurement is not convenient.